Opaleye Management Inc. bought a new position in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm bought 272,200 shares of the company’s stock, valued at approximately $2,613,000. Other institutional investors also recently bought and sold shares of the company. UBS Group AG grew its stake in shares […]
Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) – Stock analysts at Wedbush issued their FY2027 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a research report issued to clients and investors on Thursday, May 11th. Wedbush analyst D. Nierengarten forecasts that the biopharmaceutical company will post earnings of $3.38 per share for […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) had its price objective hoisted by investment analysts at Cantor Fitzgerald from $12.00 to $16.00 in a research report issued on Thursday, The Fly reports. Cantor Fitzgerald’s target price points to a potential upside of 88.68% from the company’s current price. Separately, HC Wainwright restated a “buy” rating and […]
HC Wainwright reissued their buy rating on shares of Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) in a report released on Friday morning, Benzinga reports. They currently have a $18.00 target price on the stock. HC Wainwright also issued estimates for Fennec Pharmaceuticals’ Q1 2024 earnings at $0.03 EPS, Q2 2024 earnings at $0.10 EPS, Q3 […]
HC Wainwright reissued their buy rating on shares of Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $18.00 target price on the stock. HC Wainwright also issued estimates for Fennec Pharmaceuticals’ Q1 2024 earnings at $0.03 EPS, Q2 2024 earnings at $0.10 EPS, […]